ESC Premium Access

Proprotein convertase subtilisin/kexin 9 (PCSK9) and lipopolysaccharide (LPS) in patients with atrial fibrillation. A biomarker post-hoc analysis from the ATHERO-AF cohort.

Congress Presentation

About the speaker

Professor Pasquale Pignatelli Spinazzola

Sapienza University of Rome, Rome (Italy)
0 follower

10 more presentations in this session

Inflammation implicated in the aetiology of major vascular and non-vascular diseases in East Asians

Speaker: Doctor M. Karim (Oxford, GB)


Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

Speaker: Doctor D. Takagi (Kyouto, JP)


Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients

Speaker: Doctor H. Yamamoto (Kobe, JP)


Apabetalone (RVX-208) inhibits key drivers of vascular inflammation, calcification, and plaque vulnerability through a BET-dependent epigenetic mechanism

Speaker: Doctor E. Kulikowski (Calgary, CA)


High plasma sRAGE is associated with slower carotid intima media thickness progression and lower risk for first-time coronary events and mortality

Speaker: Mrs H. Grauen Larsen (Malmo, SE)


Access the full session

Poster Session 6 - Coronary artery disease inflammation

Speakers: Professor P. Pignatelli Spinazzola, Doctor M. Karim, Doctor D. Takagi, Doctor H. Yamamoto, Doctor E. Kulikowski...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb